Skip to main content

Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice.

Author
Abstract
:

Sleep disruption is a characteristic of Alzheimer's disease (AD) that may exacerbate disease progression. This study tested whether a dual orexin receptor antagonist (DORA) would enhance sleep and attenuate neuropathology, neuroinflammation, and cognitive deficits in an AD-relevant mouse model, 5XFAD.

Year of Publication
:
0
Journal
:
Alzheimer's & dementia (New York, N. Y.)
Volume
:
5
Number of Pages
:
70-80
Date Published
:
2019
DOI
:
10.1016/j.trci.2019.01.003
Short Title
:
Alzheimers Dement (N Y)
Download citation